12-101765328-ATTT-ATTTT
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_024312.5(GNPTAB):c.1613-25dupA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00483 in 1,435,622 control chromosomes in the GnomAD database, including 17 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0027 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0051 ( 15 hom. )
Consequence
GNPTAB
NM_024312.5 intron
NM_024312.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.155
Genes affected
GNPTAB (HGNC:29670): (N-acetylglucosamine-1-phosphate transferase subunits alpha and beta) This gene encodes two of three subunit types of the membrane-bound enzyme N-acetylglucosamine-1-phosphotransferase, a heterohexameric complex composed of two alpha, two beta, and two gamma subunits. The encoded protein is proteolytically cleaved at the Lys928-Asp929 bond to yield mature alpha and beta polypeptides while the gamma subunits are the product of a distinct gene (GeneID 84572). In the Golgi apparatus, the heterohexameric complex catalyzes the first step in the synthesis of mannose 6-phosphate recognition markers on certain oligosaccharides of newly synthesized lysosomal enzymes. These recognition markers are essential for appropriate trafficking of lysosomal enzymes. Mutations in this gene have been associated with both mucolipidosis II and mucolipidosis IIIA.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 12-101765328-A-AT is Benign according to our data. Variant chr12-101765328-A-AT is described in ClinVar as [Likely_benign]. Clinvar id is 558794.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.00508 (6529/1285110) while in subpopulation NFE AF= 0.00579 (5582/964776). AF 95% confidence interval is 0.00566. There are 15 homozygotes in gnomad4_exome. There are 3140 alleles in male gnomad4_exome subpopulation. Median coverage is 20. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPTAB | NM_024312.5 | c.1613-25dupA | intron_variant | ENST00000299314.12 | NP_077288.2 | |||
GNPTAB | XM_011538731.3 | c.1532-25dupA | intron_variant | XP_011537033.1 | ||||
GNPTAB | XM_006719593.4 | c.1613-25dupA | intron_variant | XP_006719656.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNPTAB | ENST00000299314.12 | c.1613-25dupA | intron_variant | 1 | NM_024312.5 | ENSP00000299314.7 |
Frequencies
GnomAD3 genomes AF: 0.00268 AC: 403AN: 150402Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
403
AN:
150402
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00508 AC: 6529AN: 1285110Hom.: 15 Cov.: 20 AF XY: 0.00487 AC XY: 3140AN XY: 644550
GnomAD4 exome
AF:
AC:
6529
AN:
1285110
Hom.:
Cov.:
20
AF XY:
AC XY:
3140
AN XY:
644550
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00266 AC: 401AN: 150512Hom.: 2 Cov.: 33 AF XY: 0.00272 AC XY: 200AN XY: 73416
GnomAD4 genome
AF:
AC:
401
AN:
150512
Hom.:
Cov.:
33
AF XY:
AC XY:
200
AN XY:
73416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 10, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at